| Reference |
|
16394
Yamanaka T, Wong HK, Tosaki A, Bauer PO, Wada K, Kurosawa M, Shimogori T, Hattori N, Nukina N.
Large-scale RNA interference screening in mammalian cells identifies novel regulators of mutant huntingtin aggregation
PLoS One
2014
9(4):e93891
PubMed ID: 24705917
DOI: 10.1371/journal.pone.0093891
|
|
16395
Bauer PO, Hudec R, Goswami A, Kurosawa M, Matsumoto G, Mikoshiba K, Nukina N.
ROCK-phosphorylated vimentin modifies mutant huntingtin aggregation via sequestration of IRBIT
Mol Neurodegener
2012
7:43
PubMed ID: 22929228
DOI: 10.1186/1750-1326-7-43
|
|
16396
Bauer PO, Hudec R, Ozaki S, Okuno M, Ebisui E, Mikoshiba K, Nukina N.
Genetic ablation and chemical inhibition of IP3R1 reduce mutant huntingtin aggregation
Biochem Biophys Res Commun
2011
416(1-2):13-7.
PubMed ID: 22056561
DOI: 10.1016/j.bbrc.2011.10.096
|
|
16397
Bauer PO, Goswami A, Wong HK, Okuno M, Kurosawa M, Yamada M, Miyazaki H, Matsumoto G, Kino Y, Nagai Y, Nukina N.
Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein
Nat Biotechnol
2010
28(3):256-63
PubMed ID: 20190739
DOI: 10.1038/nbt.1608
|
|
16398
Wong HK, Bauer PO, Kurosawa M, Goswami A, Washizu C, Machida Y, Tosaki A, Yamada M, Knöpfel T, Nakamura T, Nukina N.
Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism
Hum Mol Genet
2008
17(20):3223-35
PubMed ID: 18658163
DOI: 10.1093/hmg/ddn218
|
|
16399
Mitsui K, Doi H, Nukina N.
Proteomics of polyglutamine aggregates
Methods Enzymol
2006
412:63-76
PubMed ID: 17046652
DOI: 10.1016/S0076-6879(06)12005-4
|
|
16400
Nagaoka U, Kim K, Jana NR, Doi H, Maruyama M, Mitsui K, Oyama F, Nukina N.
Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions
J Neurochem
2004
91(1):57-68
PubMed ID: 15379887
DOI: 10.1111/j.1471-4159.2004.02692.x
|
|
16401
Doi H, Mitsui K, Kurosawa M, Machida Y, Kuroiwa Y, Nukina N.
Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates
FEBS Lett
2004
571(1-3):171-6
PubMed ID: 15280037
DOI: 10.1016/j.febslet.2004.06.077
|
|
16402
Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi H, Kurosawa M, Nekooki M, Nukina N.
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
Nat Med
2004
10(2):148-54.
PubMed ID: 14730359
DOI: 10.1038/nm985
|
|
16403
Zemskov EA, Nukina N.
Impaired degradation of PKCalpha by proteasome in a cellular model of Huntington's disease
Neuroreport
2003
14(11):1435-8
PubMed ID: 12960759
DOI: 10.1097/00001756-200308060-00006
|
|
16404
Mitsui K, Nakayama H, Akagi T, Nekooki M, Ohtawa K, Takio K, Hashikawa T, Nukina N.
Purification of polyglutamine aggregates and identification of elongation factor-1alpha and heat shock protein 84 as aggregate-interacting proteins
J Neurosci
2002
22(21):9267-77
PubMed ID: 12417652
DOI: 10.1523/JNEUROSCI.22-21-09267.2002
|
|
16405
Jana NR, Zemskov EA, Wang Gh, Nukina N.
Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
Hum Mol Genet
2001
10(10):1049-59.
PubMed ID: 11331615
DOI: 10.1093/hmg/10.10.1049
|
|
16406
Jana NR, Tanaka M, Wang Gh, Nukina N.
Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity
Hum Mol Genet
2000
9(13):2009-18
PubMed ID: 10942430
DOI: 10.1093/hmg/9.13.2009
|
|
16407
Wang GH, Mitsui K, Kotliarova S, Yamashita A, Nagao Y, Tokuhiro S, Iwatsubo T, Kanazawa I, Nukina N.
Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells
Neuroreport
1999
10(12):2435-8
PubMed ID: 10574348
DOI: 10.1097/00001756-199908200-00001
|
Back
Top
CELL BANK Website